Llusern Scientific today announce two new commercial partnerships with the shared aim of improving UTI diagnosis and speeding up patient treatment pathways.
Llusern is delighted to appoint Syner-Med (Pharamceutical Products) Limited as its exclusive UK distributor for the Lodestar UTI testing system. Syner-Med are a well known brand within the professional urology space thanks to their range of treatments and therapeutics. The team, led by Viraj Bhatti, will be responsible for driving sales into the multitide of NHS settings where UTI testing is a daily requirement, as well as targeting opportunities within private healthcare.
The Syner-Med team are already actively selling Lodestar DX, attending the BAUS regional event in Newcastle earlier this month. We’re excited to be working with them and look forward to cooperating closely to change the way UTI patients are treated in public and private health.
Our second partnership is with Utee, a leading supplement brand, with a unique range of products designed for recurrent UTI sufferers. In 2027, together with the UTI Partnership, Llusern and Utee will launch an online testing service that allows customers to order a sample collection kit that is returned to Llusern for analysis before the patient received a treatment recommendation based on their symptoms, medical history and test result.
With the NHS struggling to manage 10 million UTI tests every year across primary and secondary care, and GP appointments becoming an increasingly scarce commodity, Llusern is working with visionary businesses to change the way patients can access UTI tests and improve antibiotic stewardship for the long-term benefit of the UK population.
